JAGSNPHARM

Jagsonpal Pharmaceuticals Limited

Healthcare · BOTH

Thu, 1 Oct, 2026
- FilingBusiness Transfer Agreement transaction consummated as of October 1, 2026, following conditions precedent fulfilment NSE ↗
- Filing
  Acquisition transaction consummated effective October 01, 2026, subsequent to fulfilment of conditions precedent under…
  BSE ↗
Wed, 23 Sept, 2026
- News
  Jagsonpal Pharmaceuticals to acquire wellness portfolio of Group Pharmaceuticals
  business-standard.com ↗
- News
  Jagsonpal Pharmaceuticals acquires Group Pharmaceuticals' wellness portfolio for ₹47 crore
  cnbctv18.com ↗
- FilingJagsonpal Pharmaceuticals acquires wellness portfolio from Group Pharmaceuticals Limited NSE ↗
- Filing
  Jagsonpal Pharmaceuticals acquires wellness portfolio of Group Pharmaceuticals Limited
  NSE ↗
- Filing
  Company acquires wellness portfolio of Group Pharmaceuticals Limited
  BSE ↗
- Filing
  Company acquires the Wellness Portfolio of Group Pharmaceuticals Limited
  BSE ↗
Fri, 18 Sept, 2026
- Filing
  47th Annual General Meeting proceedings summary filed
  BSE ↗
Thu, 27 Aug, 2026
- Filing
  Notice of 47th Annual General Meeting and Annual Report for FY 2025-26 filed
  BSE ↗
- Filing
  Annual report for FY 2025-26 filed
  BSE ↗
Mon, 24 Aug, 2026
- News
  Jagsonpal Pharmaceuticals allots 27,950 equity shares under ESOP
  business-standard.com ↗
Wed, 29 Jul, 2026
- FilingJagsonpal Pharmaceuticals informed the exchange of a change in management NSE ↗
- FilingQ1 FY2026–27 unaudited results filed for quarter ended 30 June 2026 NSE ↗
- FilingRecord date set at 04-Sep-2026 for dividend payment by Jagsonpal Pharmaceuticals NSE ↗
- FilingQ1 FY2027 financial results filed for period ended June 30, 2026 NSE ↗
- Filing
  Record date set for dividend payment on September 04, 2026
  BSE ↗
- Filing
  Unaudited financial results for Q1 FY2026-27 disclosed under Regulation 30
  BSE ↗
- Filing
  Q2 2026 unaudited financial results filed under Regulation 30, first disclosure of quarterly numbers
  BSE ↗
- Filing
  Q2 FY2027 unaudited results filed with limited review report, quarter ended June 30, 2026
  BSE ↗

Get JAGSNPHARM on your morning brief.

A calm daily reading of the filings on the stocks you actually hold — cited, no tips.

Begin